Adding SBRT to sorafenib improves survival in hepatocellular carcinoma patients
if (g_displayableSlots.mobileTopLeaderboard) {
pushDisplayAd(function() { googletag.display('div-gpt-mobile-top-leaderboard'); });
}
NRG OncologyDec 20 2024
Recent results from the Phase III NRG-RTOG 1112…
Read More...
Read More...